This issue of The Oncology Nurse-APN/PA (TON) is packed with news about what is happening in the world of oncology research and brings you information that helps you in your day-to-day practice. We highlight news from the 2013 Genitourinary Cancers Symposium and the Hematology/Oncology Pharmacy Association (HOPA) 9th Annual Conference. The HOPA news includes coverage of a study showing that a gene analysis can identify a specific mutation that allows for personalization of 5-fluorouracil therapy to reduce a patient’s risk of toxicity.
Be sure to read our coverage from the 18th Annual Conference of the National Comprehensive Cancer Network (NCCN). The inaugural NCCN Guidelines on Survivorship were unveiled at the meeting and “are intended as a library of tools for a provider to use when assessing a cancer survivor.” Our coverage from NCCN ties in with The Whole Patient article that addresses the psychosocial impact of the perception of disfigurement as a result of treatment for cancer. The authors discuss some of the biopsychosocial issues that cancer survivors may confront and how oncology nurses are at the forefront in being able to help their patients process the “new normal.”
Please let us know what you think of this issue of TON. Tell us what topics you want to see covered. We appreciate your feedback—positive and negative—about what you see in print and on the website. Visit www.TheOncologyNurse.com and email us at email@example.com.